<abstract xmlns="http://www.w3.org/1999/xhtml">Towards optimization of the pyrrolizine-5-carboxamide scaffold, a novel series of six derivatives (<bold>4a-c</bold> and <bold>5a-c</bold>) was prepared and evaluated for their anti-inflammatory, analgesic and anticancer activities. The (<italic>EZ</italic>)-7-cyano-6-((4-hydroxybenzylidene)amino)-<italic>N</italic>-(<italic>p</italic>-tolyl)-2,3-dihydro-1<italic>H</italic>-pyrrolizine-5-carboxamide (<bold>4b</bold>) and (<italic>EZ</italic>)-6-((4-chlorobenzylidene)-amino)-7-cyano-<italic>N</italic>-(<italic>p</italic>-tolyl)-2,3-dihydro-1<italic>H</italic>-pyrrolizine-5-carboxamide (<bold>5b</bold>) bearing the electron donating methyl group showed the highest anti-inflammatory activity while (<italic>EZ</italic>)-6-((4-chlorobenzylidene)amino)-7-cyano-<italic>N</italic>-phenyl-2,3-dihydro-1<italic>H</italic>-pyrrolizine-5-carboxamide (<bold>5a</bold>) was the most active analgesic agent. Cytotoxicity of the new compounds was evaluated against the MCF-7, A2780 and HT29 cancer cell lines using the MTT assay. Compounds <bold>4b</bold> and <bold>5b</bold> displayed high anticancer activity with <italic>IC</italic>50 in the range of 0.30–0.92 μmol L−1 against the three cell lines, while compound (<italic>EZ</italic>)-<italic>N</italic>-(4-chlorophenyl)-7-cyano-6-((4-hydroxybenzylidene)-amino)-2,3-dihydro-1<italic>H</italic>-pyrrolizine-5-carboxamide (<bold>4c</bold>) was the most active against MCF-7 cells (<italic>IC</italic>50 = 0.08 μmol L−1). Both the anti-inflammatory and anticancer activities of the new compounds were dependent on the type of substituent on the phenyl rings. Substituents with opposite electronic effects on the two phenyl rings are preferable for high cytotoxicity against the MCF-7 and A2780 cells. COX inhibition was suggested as the molecular mechanism of the anti-inflammatory activity of the new compounds while no clear relationship could be observed between COX inhibition and anticancer activity. Compound <bold>5b</bold>, the most active against the three cell lines, induced dose-dependent early apoptosis with 0.1–0.2 % necrosis in MCF-7 cells. New compounds showed promising drug-likeness scores while the docking study revealed high binding affinity to COX-2. Taken together, this study highlighted the significant impact of the substituents on the anti-inflammatory and anticancer activity of pyrrolizine-5-carboxamides, which could help in further optimization to discover good leads for the treatment of cancer and inflammation.</abstract>

Towards optimization of the pyrrolizine-5-carboxamide scaffold, a novel series of six derivatives (4a-c and 5a-c) was prepared and evaluated for their anti-inflammatory, analgesic and anticancer activities. The (EZ)-7-cyano-6-((4-hydroxybenzylidene)amino)-N-(p-tolyl)-2,3-dihydro-1H-pyrrolizine-5-carboxamide (4b) and (EZ)-6-((4-chlorobenzylidene)-amino)-7-cyano-N-(p-tolyl)-2,3-dihydro-1H-pyrrolizine-5-carboxamide (5b) bearing the electron donating methyl group showed the highest anti-inflammatory activity while (EZ)-6-((4-chlorobenzylidene)amino)-7-cyano-N-phenyl-2,3-dihydro-1H-pyrrolizine-5-carboxamide (5a) was the most active analgesic agent. Cytotoxicity of the new compounds was evaluated against the MCF-7, A2780 and HT29 cancer cell lines using the MTT assay. Compounds 4b and 5b displayed high anticancer activity with IC50 in the range of 0.30–0.92 μmol L−1 against the three cell lines, while compound (EZ)-N-(4-chlorophenyl)-7-cyano-6-((4-hydroxybenzylidene)-amino)-2,3-dihydro-1H-pyrrolizine-5-carboxamide (4c) was the most active against MCF-7 cells (IC50 = 0.08 μmol L−1). Both the anti-inflammatory and anticancer activities of the new compounds were dependent on the type of substituent on the phenyl rings. Substituents with opposite electronic effects on the two phenyl rings are preferable for high cytotoxicity against the MCF-7 and A2780 cells. COX inhibition was suggested as the molecular mechanism of the anti-inflammatory activity of the new compounds while no clear relationship could be observed between COX inhibition and anticancer activity. Compound 5b, the most active against the three cell lines, induced dose-dependent early apoptosis with 0.1–0.2 % necrosis in MCF-7 cells. New compounds showed promising drug-likeness scores while the docking study revealed high binding affinity to COX-2. Taken together, this study highlighted the significant impact of the substituents on the anti-inflammatory and anticancer activity of pyrrolizine-5-carboxamides, which could help in further optimization to discover good leads for the treatment of cancer and inflammation.

Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities

Department of Pharmaceutical Chemistry, Faculty of Pharmacy

Department of Medicinal Chemistry, Faculty of Pharmacy

Department of Pharmacology and Toxicology, Faculty of Pharmacy

Department of Pharmacology Medicinal and Aromatic Plants Research Institute, National Center for Research

Acta Pharmaceutica

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Towards optimization of the pyrrolizine-5-carboxamide scaffold, a novel series of six derivatives (4a-c and 5a-c) was prepared and evaluated for their...

Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities

Online veröffentlicht: 04. Juli 2018

Seitenbereich: 251 - 273

Akzeptiert: 18. März 2018

DOI: https://doi.org/10.2478/acph-2018-0026

Schlüsselwörter
pyrrolizine-5-carboxamide, anticancer, anti-inflammatory, COXs, apoptosis, substituent electronic effect

© 2018 Ahmed M. Gouda et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities

Online veröffentlicht: 04. Juli 2018

Seitenbereich: 251 - 273

Akzeptiert: 18. März 2018

DOI: https://doi.org/10.2478/acph-2018-0026

Schlüsselwörterpyrrolizine-5-carboxamide, anticancer, anti-inflammatory, COXs, apoptosis, substituent electronic effect

© 2018 Ahmed M. Gouda et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Schlüsselwörter
pyrrolizine-5-carboxamide, anticancer, anti-inflammatory, COXs, apoptosis, substituent electronic effect